Showing results (271-280 of 566) with videos related to
Sort By:
Pageof 57
RMD Open|October 19, 2016
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trialVibeke Strand, Eun Bong Lee, Roy Fleischmann, et al.Seminars in Arthritis and Rheumatism|May 24, 2012
Proceedings of the 2012 Rheumatology Winter Clinical SymposiaArthur Kavanaugh, George Martin, John J Cush, et al.Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.European Journal of Rheumatology|November 3, 2018
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparisonWalter P Maksymowych, Vibeke Strand, Peter Nash, et al.The American Journal of Medicine|May 27, 2008
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohortJeffrey D Greenberg, Mitsumasa Kishimoto, Vibeke Strand, et al.The Journal of Rheumatology|July 15, 2024
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual MeetingGretchen D Ball, Danielle Yee, Arianna J Zhang, et al.Rheumatology (Oxford, England)|September 15, 2009
Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patientsMartin Aringer, Frederic Houssiau, Caroline Gordon, et al.Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.Arthritis Research & Therapy|June 9, 2018
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 studyIain B McInnes, Philip J Mease, Georg Schett, et al.Expert Review of Molecular Diagnostics|October 28, 2022
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritisJeffrey R Curtis, Vibeke Strand, Steven Golombek, et al.Pageof 57